newsfilter
← Latest News
Business Wire·

Zai Lab Announces Updates to China's National Reimbursement Drug List

Zai Lab Limited (NASDAQ:ZLAB, HKEX: 9688)) today announced that the following medicines and indications have been renewed in the 2025 National Reimbursement Drug List (NRDL) released by China's National Healthcare